Stock picks with research | support | resistance and technical analysis for trading | Day trading | stock investing in the market

• About US

Market Activity

Premium Plan

Trading Technologies

Day Trading

Stock Trading

Stock Trading Strategy

Technical Strategy

Breakout Stocks

Penny Stock investing

stock Breakout for day trading

Stock : EBS	\| Stock Recommendations : Buy
Sector : Biotech & Drugs	\| First resistance : 18.19
Stock Name : EMERGENT BIOSOLUTIONS INC COM	\| Second resistance :
Buy Near :	\| Third resistance :
StopLoss :	\| First Support : 16.11
Posted date : 11/2/2008 12:00:00 AM	\| Second Support : 14.60

Emergent BioSolutions Inc. com (EBS) Stock has given a buy signal, with rising moving average. Stockhastic and ADX also given a buy signal.

Emergent BioSolutions Inc. com (EBS) announced on 10/1/08, it will receive between $364 million and $404 million for new contracts to supply the U.S. government with anthrax vaccines. Emergent BioSolutions Inc. com (EBS) is a Biotechnology company. As per technical analysis, Stock analysis and fundamentally this Stock looks good candidate for portfolio investment. Emergent BioSolutions Inc. com Stock you can consider for Stock Market Investment, Swing Trading, Stock trading, Stock Investing, Day trading, Stock picks, Breakout Stocks. Due to Stock market and economic condition keep tight stop loss on all position. You can buy this Stock near $18

Portfolio stock

Recent News Head Lines

Emmaus (EMMA) to Report Q4 Earnings: What's in the Cards?
(Thu, 06 Feb 2020 15:44:03 +0000)
Investors look forward to updates on key drug Endari's expansion plans when Emmaus (EMMA) releases fourth-quarter 2019 results.

Emergent BioSolutions to Release Fourth Quarter and Full Year 2019 Financial Results and Conduct a Conference Call on February 20, 2020
(Mon, 03 Feb 2020 21:30:10 +0000)
GAITHERSBURG, Md., Feb. 03, 2020 -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Thursday, February 20, 2020 at 5:00 pm (Eastern Time) to discuss the.

Emergent BioSolutions Receives Positive CHMP Opinion for Vaxchora; Anticipates Near-Term Approval by European Medicines Agency
(Fri, 31 Jan 2020 14:26:54 +0000)
GAITHERSBURG, Md., Jan. 31, 2020 -- Emergent BioSolutions Inc. (NYSE:EBS) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European.

Does The Emergent BioSolutions Inc. (NYSE:EBS) Share Price Fall With The Market?
(Thu, 23 Jan 2020 11:17:28 +0000)
Anyone researching Emergent BioSolutions Inc. (NYSE:EBS) might want to consider the historical volatility of the share...

Emergent (EBS) Posts Preliminary '19 Results, Gives 2020 View
(Tue, 14 Jan 2020 15:03:03 +0000)
Emergent (EBS) narrows revenue view for 2019 and expects a consistent rise in Narcan nasal spray sales during 2020.

Never go against major trend for day trading | stock trading

Home for ۩ Day Trading | Breakout Stock trading system | Penny Stock Investing | Market Research

All Rights Reserved © 2000-2006 Flyingstock.com
Chart courtesy of StockCharts.com
Portfolio stock - EMERGENT BIOSOLUTIONS INC COM for Stock investing stock trading day trading

This Service is solely an information service provided by the automated software tool & is for entertainment purposes only. It should be understood that there is no guarantee that past performance of our stock trading system or day trading Strategy or Penny stock picks will be indicative of future results.